drugset / Trial / NCT03663582
Study of Teduglutide in Japanese Participants With Short Bowel Syndrome
NaSingle-groupOpen-labelTreatment
Summary
The objectives of this clinical study are to evaluate the safety, efficacy, and pharmacokinetics (PK) of teduglutide in Japanese participants with short bowel syndrome (SBS) who are dependent on parenteral nutrition/intravenous (PN/IV) over a 24-week treatment period.
Timeline
- Start
- 2018-07-06
- Primary completion
- 2019-08-06
- Completion
- 2019-08-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Teduglutide | Peptide | 0.05 mg/kg | Subcutaneous |